Experimental Infection of Rabbits with Rabbit and Genotypes 1 and 4 Hepatitis E Viruses by Ma, Hongxia et al.
Experimental Infection of Rabbits with Rabbit and
Genotypes 1 and 4 Hepatitis E Viruses
Hongxia Ma
1,4, Lin Zheng
2, Yunbo Liu
3, Chenyan Zhao
1, Tim J. Harrison
5, Yuyuan Ma
2, Shuhua Sun
3,
Jingang Zhang
2, Youchun Wang
1*
1Department of Cellular Biology, National Institute for the Control of Pharmaceutical and Biological Products, Beijing, China, 2Laboratory for Viral Detection, National
Center of Biomedical Analysis at the Institute of Transfusion Medicine, AMMS, Beijing, China, 3Institute of Laboratory Animal Science, Chinese Academy of Medical
Sciences and Peking Union Medical College, Panjiayuan, Beijing, China, 4Henan Center for Disease Control and Prevention, Zhengzhou, China, 5Division of Medicine,
University College London Medical School, Windeyer Building, London, United Kingdom
Abstract
Background: A recent study provided evidence that farmed rabbits in China harbor a novel hepatitis E virus (HEV) genotype.
Although the rabbit HEV isolate had 77–79% nucleotide identity to the mammalian HEV genotypes 1 to 4, their genomic
organization is very similar. Since rabbits are used widely experimentally, including as models of infection, we investigated
whether they constitute an appropriate animal model for human HEV infection.
Methods: Forty-two SPF rabbits were divided randomly into eleven groups and inoculated with six different isolates of
rabbit HEV, two different doses of a second-passage rabbit HEV, and with genotype 1 and 4 HEV. Sera and feces were
collected weekly after inoculation. HEV antigen, RNA, antibody and alanine aminotransferase in sera and HEV RNA in feces
were detected. The liver samples were collected during necropsy subject to histopathological examination.
Findings: Rabbits inoculated with rabbit HEV became infected with HEV, with viremia, fecal virus shedding and high serum
levels of viral antigens, and developed hepatitis, with elevation of the liver enzyme, ALT. The severity of disease
corresponded to the infectious dose (genome equivalents), with the most severe hepatic disease caused by strain GDC54-
18. However, only two of nine rabbits infected with HEV genotype 4, and none infected with genotype 1, developed
hepatitis although six of nine rabbits inoculated with the genotype 1 HEV and in all rabbits inoculated with the genotype 4
HEV seroconverted to be positive for anti-HEV IgG antibody by 14 weeks post-inoculation.
Conclusions: These data indicate that rabbits are an appropriate model for rabbit HEV infection but are not likely to be
useful for the study of human HEV. The rabbit HEV infection of rabbits may provide an appropriate parallel animal model to
study HEV pathogenesis.
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Introduction
Hepatitis E virus (HEV) is transmitted between humans by the
fecal-oral route and causes an acute, self-limiting hepatitis with
high morbidity in young adults. Hepatitis E is an important public
health concern in many developing countries in Asia and Africa
and occurs sporadically in some industrialized countries. HEV is a
small, non-enveloped virus with a single-stranded, positive-sense
RNA genome of approximately 7.2 kb containing three open
reading frames (ORFs), ORF1, ORF2 and ORF3, where ORF3
partially overlaps ORF2 [1,2,3]. Currently, there are four
recognized genotypes of HEV that can infect mammals but only
one serotype [4,2,5,6,7,8].
Since the first non-human strain of HEV was isolated from a pig
in the United States in 1997 and designated swine HEV [9],
antibodies to HEV have been detected in a wide range of domestic
and wild mammals, including cattle, sheep, goats, horses, rats and
rabbits [10,11,12]. Zoonotic transmission of HEV is increasingly
recognized and virological evidence of infection with HEV has
been found in domestic swine, wild boar, deer and horses,
particularly genotypes 3 and 4 [13,12,14]. Avian HEV was
characterized recently in chickens and is genetically and
antigenically related to the mammalian genotypes but is
phylogenetically distinct [15]. A recent study provided evidence
that farmed rabbits in China harbor a reservoir of a novel
genotype of HEV [10]. Although the overall nucleotide similarity
of rabbit HEV is only 77–79%, compared with genotypes 1–4, the
relationship of rabbit HEV to the mammalian genotypes is much
closer than to avian HEV.
As the presumed natural reservoir of HEV genotypes 3 and 4,
pigs are able to amplify the virus but only develop subclinical
disease [16,13,17]. Although pigs could be used as an experi-
mental model of genotypes 3 and 4 HEV infection but cannot
be infected with genotype 1 HEV and difficulties in handling,
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emulate human disease caused by genotypes 3 and 4, limit the value
of this animal model for studying the disease aspect of HEV
infection. A number of non-human primate species, such as
cynomolgus macaques, rhesus, owl, and African green monkeys
and chimpanzees are susceptible to HEV infection and some
have been used successfully as animal models of hepatitis E
[20,21,22,23,24,25]. The most valuable are macaques because the
disease is reproduced readily in them. The course of infection in
experimentally-infected primates is similar to that in humans with
some variations in incubation periods [20,21,22,23,24,25]. How-
ever, these non-human primate animal models also are restricted by
limited resources, ethical concerns, and difficult and expensive
experimental procedures. Another variety of HEV was identified
and characterized in chickens and evaluated as a model for the
study of HEV infection [26]. Although the genomic organization of
avian HEV is very similar to HEV genotypes 1–4, the overall
nucleotide identity is only around 50% [27] and the virus is
phylogeneticallydistinct from the mammalianHEVgenotypes [15].
At present, the advancement of HEV research has been
hampered to by the lack of an effective in vitro culture system
and a small animal model of HEV infection would be extremely
valuable. This study investigated the experimental infection of
specific pathogen-free (SPF) rabbits with HEV isolated from
rabbits, to study systematically HEV pathogenesis and replication
of rabbit HEV in its natural host. Furthermore, we also studied the
infection of rabbits with HEV genotypes 1 and 4 to characterize
the clinical course associated with cross-species HEV infection.
Materials and Methods
Ethics Statement
The animal experimentation was approved by the Committee
of Laboratory Animal Welfare and Ethics, National Institute for
the Control of Pharmaceutical and Biological Products. The
regulation for the review committee of laboratory animal welfare
and ethics and protocol for the review on laboratory animal
welfare and ethics, National Institute for the Control of
Pharmaceutical and Biological Products, were followed.
Viruses
The rabbit strain of HEV was originally recovered from serum
samples from rabbits bred in two farms in Gansu province, China
[10]. All six of the original rabbit HEV infectious plasma samples
and the second-passage samples (GDC54-18) of rabbit HEV were
generated from rabbits and titered by real-time PCR. The titers of
GDC9, RC12, GDC22, GDC37, GDC46, GDC54 and GDC54-
18 used as the inocula for this study, were 1.03610
3, 4.69610
1,
6.35610
3, 2.59610
4, 6.40610
4, 6.93610
4 and 6.74610
6 genome
equivalents per mL, respectively. The second-generation infectious
stock of GDC54-18 was recovered from the feces of a rabbit
experimentally-infected with the GDC54 HEV strain during the
acute phase of infection. The virus suspensions were stored at
270uC for later use. The HEV RNA content of virus samples were
determined prior to inoculation by reverse transcription-polymerase
chain reaction (RT-PCR), as described previously [20,23].
Two strains of HEV isolated from humans were used for
challenge. A genotype 4 strain (RH4) was collected from the feces
of an individual with acute hepatitis E in Beijing, China and a
genotype 1 strain (RH1) was collected from the feces of patients
with sporadic hepatitis E in the Xinjiang Autonomous Region,
China [20,28,29]. The fecal samples were diluted in phosphate-
buffered saline (PBS; pH 7.4) containing 1% bovine serum
albumin (BSA) to make a 10% (wt/vol) suspension, clarified by
centrifugation at 3000 rpm at room temperature for 10 min and
filtered through 0.45 mm and 0.22 mm filters. The resulting
suspensions were aliquotted at 1 ml/vial and kept under liquid
nitrogen for later analysis. Rabbits were inoculated with 1.10610
6
genome equivalents of RH1 or 1.14610
7 genome equivalents of
RH4 [30].
Animals
Forty-two 7-week old SPF rabbits weighing between 800 and
1000 g were obtained from the National Institute for the Control
of Pharmaceutical and Biological Products, in Beijing, China.
Prior to inoculation, all rabbits were confirmed negative for anti-
rabbit HEV antibodies and antigens by an enzyme-linked
immunosorbent assay (ELISA).
Experimental Design
Rabbits were divided randomly into eleven groups and
inoculated intravenously with different doses of the various HEV
isolates (Table 1). Each rabbit was housed in a separate cage and
fed twice a day, with access to drinking water ad libitum.
Sample Collection and Processing
Blood samples and feces were collected weekly following virus
challenge. Serum samples were tested for levels of the liver
enzyme, alanine aminotransferase (ALT), HEV antigen and anti-
HEV antibodies using standard methods, as described below.
Serum and feces samples were tested weekly for HEV RNA by
real-time PCR, as reported previously [31]. Furthermore, positive
samples were tested using reverse transcription-PCR (RT-PCR)
with another two pairs of primers [20,23,28] and the positive
amplicons sequenced. In fact, there was no animal necropsied at
planned time because the number of rabbits for each group was
limited. Thus only a few rabbits were necropsied randomly
following accidental death during the study or at the end of the
study, and samples of liver were collected.
Pathology and Histopathology
No gross pathological lesions were observed in the livers during
necropsies. Liver samples collected at necropsy were fixed in 10%
neutral buffered formalin and processed for routine histological
examination. Each specimen was embedded in paraffin and cut
Table 1. Challenge schedules for rabbits inoculated with
different HEV strains.
Inoculum strain
(Groups)
Animals
per group
Infectious dose:
genome equivalents
RH1 9 1.10610
6
RH4 9 1.14610
7
GDC9 2 1.03610
3
RC12 2 4.69610
1
GDC22 2 6.35610
3
GDC37 2 2.59610
4
GDC46 2 6.40610
4
GDC54 2 6.93610
4
Control 4 0
1GDC54-18 4 6.74610
6
2GDC54-18 4 1.35610
7
doi:10.1371/journal.pone.0009160.t001
Rabbit HEV Infection
PLoS ONE | www.plosone.org 2 February 2010 | Volume 5 | Issue 2 | e9160into 3 mm serial sections, stained with hematoxylin–eosin and
subjected to histopathological examination by light microscopy.
Determination of ALT Concentrations
All rabbits were monitored weekly after inoculation for 14
weeks. ALT concentrations in sera were measured on the day of
collection using an automated analyzer (Hitachi 912; Roche,
Indianapolis, USA) according to the manufacturer’s instructions.
Biochemical evidence of hepatitis was recorded when the serum
ALT concentration exceeded the baseline ALT level by more than
two-fold, as defined by a peak ALT value that was equal to or
greater than twice the pre-challenge values. These criteria were
based on the correlation between the level of ALT increase and
liver pathology described in a previous study using a non-human
primate as an animal model of hepatitis [23].
ELISA for HEV Antigen and Antibody
All serum samples were tested for the presence of HEVantigenas
described previously [32] and for antibody by an enzyme-linked
immunosorbent assay based on the virus E2 protein (amino acids
394–606 of HEV ORF2) [23], according to the manufacturer’s
instructions (Wantai, Beijing, China). Sample/cutoff (S/CO) values
were calculated and values .1 were considered positive, as
determined previously [29]. Convalescent-phase sera from exper-
imentally-infected rabbits and sera from unbinfected SPF rabbits
were included as positive and negative controls, respectively.
RT-PCR to Detect HEV RNA
To determine the genomic dose of each inoculum, RNA was
extracted from sera and fecal suspensions using a spin-column kit
and the procedures of Kinghawk Biopharmaceutical Company
(Beijing, China) and evaluated by a real-time fluorescence RT-
PCR assay with primers based on the conserved regions of HEV
ORF3, as reported previously [31]. In order to detect HEV RNA
in the feces and sera of inoculated and non-inoculated rabbits,
RNA was extracted from those samples using the method
described above and tested for HEV genomic RNA by nested
RT-PCR with primers derived from the ORF2 region [20,23,28].
A final amplification product of about 347 bp was then analyzed
by electrophoresis through a 1.0% agarose gel and visualized by
ethidium bromide staining. The positive amplicons were directly
sequenced. Negative and positive control fecal suspensions were
included in each assay. RNA extraction and other pre-PCR
amplification steps were performed in a separate clean room to
minimize cross-contamination.
Results
Clinical Signs
Clinical signs, such as diarrhea and jaundice, were not observed;
however, some rabbits decreased food consumption for part of the
duration of the study. Some rabbits suffered accidental death
during blood collection by heart puncture.
Seroconversion to HEV Antibodies
Prior to inoculation, all rabbits were seronegative for HEV. All
control rabbits remained seronegative throughout the study. Anti-
HEV IgG was detected in six of nine rabbits inoculated with the RH1
strain HEV (group RH1) and in eight of nine rabbits inoculated with
the RH4 strain (group RH4) by 14 weeks post-inoculation (wpi)
(Table 2). All rabbits inoculated with rabbit HEV were seropositive at
the end of the study with the exception of one rabbit in group
GDC54, based on the time point at the end of the study. These
rabbits which died before seroconversion were not included. This
rabbit was inoculated with GDC54 and was antibody-positive for
only 3 weeks but then tested antibody-negative at 12 wpi. The
dynamic patterns of anti-HEV IgG antibodies detected in the groups
RH1,RH4and all six groups inoculated with the non-passaged rabbit
HEV strains, regardless of whether they were inoculated with
genotype 1, 4 or rabbit HEV were very similar in S/CO values that
increased gradually and were not statistically different (Fig. 1B). In
fact, the changing trends of antibody levels in the inoculated groups
were alsosimilar and increased graduallyby the end of the study, with
the only discernable difference being the time to seroconversion.
However, the only groups to not follow these trends were
groupGDC54, whose antibody levels peaked at 10 wpi and then
returned to the baseline levels at 12 wpi, and group 1GDC54-18,
whose antibody levels increased rapidly at 11 wpi (Fig. 1A).
Detection of HEV Antigens
All rabbits were negative for HEV antigen prior to inoculation
and no control rabbits seroconverted throughout the study. The
mean S/CO values of antigenemia differed between the rabbits
inoculated with genotypes 1 and 4 and rabbits inoculated with the
Table 2. Time course for seroconversion of rabbits inoculated with HEV.
Inoculum strain (Groups) No. of seropositive rabbits/total no. tested at indicated weeks post-inoculation
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
RH1 0/9 0/9 0/9 0/9 0/9 0/9 1/9 2/9 5/9 5/9 5/9 6/9 6/9 6/9 6/9
RH4 0/9 0/9 0/9 0/9 0/9 1/9 2/9 4/9 4/8 4/8 4/8 4/8 7/8 7/8 7/8
GDC9 0/2 0/2 0/2 0/2 0/2 1/2 1/2 0/2 0/2 1/1 1/1 1/1 1/1 1/1 1/1
RC12 0/2 0/2 0/2 0/2 1/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2
GDC22 0/2 0/2 0/2 0/2 1/2 1/2 1/2 1/2 1/2 2/2 2/2 2/2 2/2 2/2 2/2
GDC37 0/2 0/2 0/2 0/2 0/2 0/2 0/2 1/2 1/2 1/2 1/2 1/2 2/2 2/2 2/2
GDC46 0/2 0/2 0/2 0/2 0/2 0/2 1/2 1/2 1/2 1/2 1/2 2/2 2/2 2/2 2/2
GDC54 0/2 0/2 0/1 0/1 0/1 0/1 0/1 0/1 0/1 1/1 1/1 1/1 0/1 0/1 0/1
Control 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4
1GDC54-18 0/4 0/4 0/4 0/4 0/4 0/3 1/3 1/3 2/3 1/3 2/3 2/3 1/1 1/1 1/1
2GDC54-18 0/4 0/4 0/4 0/4 0/4 0/4 0/4 1/4 1/4 4/4 4/4 4/4 4/4 4/4 4/4
doi:10.1371/journal.pone.0009160.t002
Rabbit HEV Infection
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antigen was detected in the sera of two of the nine group RH4
rabbits, one from 2 to 4 wpi and the other from 6 to 14 wpi. No
antigen was detected in group RH1 rabbits during the course of
observation (Table 3). HEV antigen was detected in half of rabbits
inoculated with the non-passaged rabbit HEV isolates, the main
differences being in the time to peak antigen levels (Fig. 2A). Some
rabbits inoculated with GDC54 showed double peaks, regardless
of whether original isolates or second-passage inocula were used.
The antigen levels in the 2GDC54-18 inoculated group of rabbits
remained elevated from 1 to 9 wpi and from 11 to 14 wpi, until the
end of the study. For group 1GDC54-18, antigen levels also
showed a peak at 9 wpi and returned to baseline levels at 12 wpi. It
is noteworthy that just one rabbit of this group survived until the
end of the study because of the accidental death of the others at
the 11 wpi. This surviving rabbit was negative for HEV antigen
throughout the study.
Detection of HEV RNA in Serum and Fecal Samples from
Rabbits
Pre-inoculation samples taken from all rabbits were negative for
HEV RNA and all uninoculated control rabbits remained negative
throughout the experiment. Rabbit HEV RNA was detected
variably in serum and fecal samples from rabbits in the various
groups (Table 4).
Viremia was detected in sera from 1 to 3 wpi in two of nine
RH4 group rabbits inoculated with genotype 4 HEV, with one
animal intermittently positive thereafter. No viral RNA was
detected in any rabbit of the RH1 group inoculated with HEV
genotype 1. Viremia was detected only three times among any of
the six groups of rabbits inoculated with the non-passaged rabbit
HEV isolates, including one of two rabbits in the GDC9 group at
8 wpi, one of two in the RC12 group at 10 wpi and one of two in
the GDC46 group at 10 wpi. For the 1GDC54-18 group rabbits,
viremia was detected from 1 to 2 wpi and 5 to 6 wpi. HEV RNA
was first detected in the serum of two of four rabbits in the
2GDC54-18 group at 1 wpi and was intermittently positive
thereafter, up to 11 wpi.
Fecal shedding of viruses was not detected in group RH1. For
group RH4 rabbits, HEV RNA was first detected in feces from
two of the nine rabbits at 2 wpi and one them was intermittently
positive thereafter. All of the groups inoculated with the non-
passaged rabbit HEV isolates were intermittently positive for HEV
RNA in feces, except group RC12. For the group 1GDC54-18
Figure 1. Time course of seroconversion to anti-HEV in SPF rabbits inoculated with different virus isolates. (A) The mean ELISA signal-
to-cutoff (S/CO) values for all rabbits from each group at each week post-inoculation are plotted. (B) All rabbits from groups 3 to 8 inoculated with
the non-passaged HEV are named R1ST and the combination of groups RH1 and RH4 are named RH.
doi:10.1371/journal.pone.0009160.g001
Rabbit HEV Infection
PLoS ONE | www.plosone.org 4 February 2010 | Volume 5 | Issue 2 | e9160Figure 2. Time course of serological appearance of HEV antigens in inoculated SPF rabbits. (A) The weekly mean ELISA signal-to-cutoff
(S/CO) values for all rabbits from each group are plotted. (B) All rabbits from groups 3 to 8 inoculated with the non-passaged HEV are named R1ST
and the combination of groups RH1 and RH4 are named RH.
doi:10.1371/journal.pone.0009160.g002
Table 3. Time course for the presence of HEV antigens in the sera of inoculated rabbits.
Inoculum (Groups) No. of seropositive rabbits/total no. tested at indicated weeks post-inoculation
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
RH1 0/9 0/9 0/9 0/9 0/9 0/9 0/9 0/9 0/9 0/9 0/9 0/9 0/9 0/9 0/9
RH4 0/9 0/9 1/9 1/9 1/9 0/9 1/9 1/9 1/8 1/8 1/8 1/8 0/8 1/8 1/8
GDC9 0/2 0/2 0/2 0/2 0/2 1/2 1/2 1/2 0/2 0/1 0/1 0/1 0/1 0/1 0/1
RC12 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2
GDC22 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2
GDC37 0/2 0/2 0/2 0/2 0/2 1/2 1/2 1/2 1/2 1/2 1/2 1/2 1/2 1/2 1/2
GDC46 0/2 1/2 1/2 1/2 1/2 1/2 1/2 1/2 1/2 1/2 1/2 0/2 0/2 0/2 0/2
GDC54 0/2 2/2 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1
Control 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4
1GDC54-18 0/4 0/4 1/4 1/4 1/4 1/3 1/3 1/3 1/3 2/3 1/3 1/3 0/1 0/1 0/1
2GDC54-18 0/4 0/4 0/4 3/4 3/4 2/4 2/4 2/4 2/4 2/4 2/4 2/4 2/4 2/4 2/4
doi:10.1371/journal.pone.0009160.t003
Rabbit HEV Infection
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until 4 to 11 wpi. Three of the four group 2GDC54-18 rabbits
were HEV RNA positive at 4 wpi and from 6 to 8 wpi.
The viruses recovered from selected experimentally-infected
rabbits were sequenced to confirm that they were derived from the
original inoculum, with nucleotide identity 99–100% to the
original inoculum.
ALT Levels in Serum
No instant elevations in serum ALT-levels were observed in the
four control rabbits, nine rabbits each in groups RH1 and RH4
during the entire study (Fig. 3A). However, an increasing trend was
observed for each rabbit, and significantly increased serum ALT
levels were observed during the latter period of fecal HEV RNA
excretion for two RH4 group rabbits. The differences in minimum
and maximum values of serum ALT for these two rabbits were 63
and 97 U/L. For the 12 rabbits inoculated with the first-generation
rabbit HEV, the ALT responses differed over time, similar to the
occurrence of antigens and HEV RNA. For the RC12 and GDC46
group rabbits, levels of ALT in sera showed no obvious increase
during the study. ALT levels of GDC54 group rabbits were
significantly elevated, with a peak value of 157 U/L at 9 wpi and
172 U/L at 14 wpi. Therefore, we selected viruses recovered from
this infected group for the second-generation infectious stocks.
Accordingly, dramatic elevations in serum ALT were observed for
two 2GDC54-18 group rabbits with peak values at 10 wpi as highas
181 and 426 U/L, respectively. The 1GDC54-18 group, however,
was an exception as peak ALT levels were not high, probably due to
the frequent occurrence of accidental death not associated with
HEV infection. The strongest ALT response was observed in the
2GDC54-18 group (Fig. 3B). Overall, the rabbits in six groups
inoculated with non-passaged rabbit HEV isolates showed a
stronger ALT response than rabbits inoculated with genotypes 1
and 4 despite those rabbits being inoculated with muchhigher doses
in terms of genome equivalents of viruses.
Liver Histopathology
No statistical data on the pathological signs of HEV infection in
the liver can be reported because liver biopsies were not performed
and no rabbits were regularly necropsied during the entire study.
Some rabbits that showed elevated ALT levels when they were
necropsied at the end of the study or died due accidentally and all
control rabbits were investigated for liver pathology. Multifocal
lymphohistiocytic infiltrates were distributed irregularly in the liver
of a rabbit from group RH4 (Fig. 4C) and locally hepatocellular
necrosis was observed in liver sections from a 2GDC54-18 group
rabbit (Fig. 4A and B). No pathological signs of HEV infection
were observed in liver sections of control group rabbits (Fig. 4D).
Discussion
The lack of an effective cell culture system and a small animal
model has hampered the progress of HEV research. Experimental
infections of pigs and non-human primates with HEV have been
well documented [33,13,16,23,24,34,20,19]. In addition, chickens
[26] and rats [35] have also been assessed as animal models for
studying HEV replication and pathogenesis. The discovery of a
novel genotype of HEV that infects rabbits prompted us to
evaluate these animals as a model for the study of HEV. Full-
length sequence and phylogenetic analyses have revealed that the
sequences isolated from rabbits represent a novel genotype of
HEV genetically related to mammalian HEV, most closely to
genotype 3. In addition, test data showed that there is significant
cross-reactivity of antibodies produced during infection of both
rabbit HEV and HEV genotypes 1 and 4, especially to the ORF2
polypeptides (data not shown). The current study investigated
rabbit HEV replication and pathogenesis in a homologous animal
model and also determined whether HEV genotypes 1 and 4,
isolated from humans, also can infect rabbits.
Six original isolates of rabbit HEV were used to infect 12 SPF
rabbits. Based on a 304 bp region of ORF2, the rabbit HEV strains
used in this study shared 84–99% identity and are 73–77, 70–76,
75–82,71–77, and 53–65% identical to the corresponding regionsof
human HEV genotypes 1, 2, 3, 4, and avian HEV, respectively [10].
The maximum dose of virus available for each strain was used to
infectrabbits.Themarkersofinfection,HEVRNAandantigen,and
of seroconversion, anti-HEV antibody, were detected in sera or feces
of inoculated and non-inoculated rabbits. The sensitivity for
RT-PCR using in the present study can reach to 5.6610
3 copies/
reaction[36]todetectHEVRNA.TheconcordancesbetweenHEV
antigen and HEV RNA detected by using the same assays as in the
present study was 77.1% with significant correlations [37].
Consequently, the clinical symptoms manifested among the different
Table 4. Detection of HEV RNA in sera and feces collected weekly from rabbits inoculated with HEV isolates.
Inoculum
(Groups) No. of positive sera (no. of positive feces)/total no. tested at indicated weeks post-inoculation
01234567891 0 1 1 1 2 1 3 1 4
RH1 0(0)/9 0(0)/9 0(0)/9 0(0)/9 0(0)/9 0(0)/9 0(0)/9 0(0)/9 0(0)/9 0(0)/9 0(0)/9 0(0)/9 0(0)/9 0(0)/9 0(0)/9
RH4 0(0)/9 2(0)/9 2(2)/9 2(1)/9 1(1)/9 0(0)/9 1(1)/9 0(1)/9 1(1)/8 0(0)/8 1(0)/8 1(1)/8 0(1)/8 1(0)/8 0(0)/8
GDC9 0(0)/2 0(0)/2 0(1)/2 0(0)/2 0(1)/2 0(2)/2 0(1)/2 0(1)/2 1(1)/2 0(1)/1 0(0)/1 0(0)/1 0(0)/1 0(0)/1 0(0)/1
RC12 0(0)/2 0(0)/2 0(0)/2 0(0)/2 0(0)/2 0(0)/2 0(0)/2 0(0)/2 0(0)/2 0(0)/2 1(0)/2 0(0)/2 0(0)/2 0(0)/2 0(0)/2
GDC22 0(0)/2 0(0)/2 0(0)/2 0(0)/2 0(0)/2 0(1)/2 0(0)/2 0(1)/2 0(1)/2 0(1)/2 0(1)/2 0(1)/2 0(1)/2 0(1)/2 0(1)/2
GDC37 0(0)/2 0(0)/2 0(0)/2 0(2)/2 0(2)/2 0(1)/2 0(1)/2 0(1)/2 0(1)/2 0(1)/2 0(1)/2 0(1)/2 0(1)/2 0(1)/2 0(1)/2
GDC46 0(0)/2 0(0)/2 0(0)/2 0(0)/2 0(1)/2 0(1)/2 0(1)/2 0(1)/2 0(1)/2 0(1)/2 1(2)/2 0(0)/2 0(0)/2 0(0)/2 0(0)/2
GDC54 0(0)/2 0(0)/2 0(0)/1 0(1)/1 0(1)/1 0(1)/1 0(1)/1 0(1)/1 0(1)/1 0(1)/1 0(1)/1 0(1)/1 0(1)/1 0(1)/1 0(1)/1
Control 0(0)/4 0(0)/4 0(0)/4 0(0)/4 0(0)/4 0(0)/4 0(0)/4 0(0)/4 0(0)/4 0(0)/4 0(0)/4 0(0)/4 0(0)/4 0(0)/4 0(0)/4
1GDC54-18 0(0)/4 0(1)/4 1(0)/4 2(0)/4 0(1)/4 1(1)/3 1(2)/3 0(1)/3 0(1)/3 0(1)/3 0(1)/3 0(1)/3 0(0)/1 0(0)/1 0(0)/1
2GDC54-18 0(0)/4 2(1)/4 1(0)/4 2(2)/4 2(3)/4 0(1)/4 1(3)/4 2(3)/4 2(3)/4 2(1)/4 1(1)/4 1(1)/4 0(1)/4 0(1)/4 1(2)/4
doi:10.1371/journal.pone.0009160.t004
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rabbit HEV isolates seroconverted to HEV by 3 months
postinoculation, except for animals that died accidentally midway
through the study. The timing of the appearance of antibody was
related to other clinical markers of disease, i.e., if viral antigens
appeared early in sera, then the corresponding antibodies appeared
later. As expected, rabbits inoculated with lower doses of virus in
terms of genome equivalents showed a weaker serological response.
For example, rabbits inoculated with RC12 strain of HEV
(4.69610
1 genome equivalents) seroconverted at 4 wpi without
antigenemia or HEV RNA in feces. In contrast, rabbits in the
GDC54 inoculated group developed more severe clinical symptoms
following challenge with a larger virus inoculum (6.93610
4 genome
equivalents). Nonetheless, we infected rabbits successfully with HEV
isolated from rabbits and proved that they are a suitable animal
model for the study of rabbit HEV.
Because the virulence of the first-generation rabbit HEV was
limited, we used virus recovered from the feces of rabbits inoculated
with the GDC54 strain of HEV as a second passage inoculum for
the further studies. The second passage HEV GDC54-18 virus
inoculum was used to infect another eight rabbits, using two
different doses. As expected, challenging with higher doses of virus
in terms of genome equivalents caused a more severe hepatitis.
Serum ALT levels, which are indicative of recent liver damage and
suggestive of an acute infection, peaked at 10 wpi (Fig. 3B) with a
value up to 181 U/L for 2GDC54-18 group rabbits. In addition,
local hepatocellular necrosis was observed in liver sections from a
rabbit in the 2GDC54-18 group (Fig. 4A and B). Unfortunately,
only one of four 1GDC54-18 group rabbits survived up to 12 wpi
because of the accidental death of the others in the group, not
associated with virus infection. The results from this study indicate
that rabbits are a useful animal model for HEV infection due to the
recapitulation of hepatic disease and typical HEV replication and
pathogenesis. However, only few rabbits were necropsied at non-
planned time points, a larger number of animals with higher
infectious dose and planned optimal necropsy schedule are needed
to definitively characterize the hepatic lesions associated with rabbit
HEV infection in rabbits. Such a study will be designed in future.
Figure 3. Levels of the lalanine aminotransferase (ALT) in sera from inoculated and control rabbits. (A) The mean ALT values of all
rabbits from each group at each week post-inoculation are plotted. (B) All rabbits from groups 3 to 8 inoculated with the non-passaged rabbit HEV
are named R1ST and the combination of groups RH1 and RH4 are named RH.
doi:10.1371/journal.pone.0009160.g003
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human HEV could infect rabbits. So far, no evidence has proved
that human genotypes 1 and 2 HEV can infect pigs, although
genotypes 3 and 4 can infect both human and pigs. In addition to
pigs, many other animals have been shown to be susceptible to
infection with genotypes 3 and 4 HEV and can serve as a reservoir
of HEV that can amplify the virus and transmit to humans
[38,39,40,41,42,43,12,26,10]. Although different HEV types have
very similar genomic organization, they may vary in their ability to
infect different mammalian species. Whether rabbit HEV may be
transmitted to humans is not known [10]. In this study, No HEV
RNA and antigens were observed in the sera of the nine RH1 group
rabbits, with no fecal shedding. Serum ALT levels showed no
instantelevationsinaccordancewiththelackofpathologicalsignsof
HEV infection in liver. However, six of nine animals became anti-
HEV antibody positive. The doses of virus, in terms of genome
equivalents, inoculated into the animals were much higher for this
group than for groups inoculated with non-passaged rabbit HEV
isolates. Whether the antibody was induced by HEV infection or
immunization with a high dose HEV is not clear and requires
further study. For the RH4 group rabbits inoculated with the
highest virus inoculum (1.14610
7 genome equivalents) of all test
animals, seven rabbits seroconverted at 14 wpi. In summary,
seroconversion, viremia, fecal virus shedding or serum liver enzyme
elevation were observed in two of nine RH4 group rabbits,
suggesting evidence of virus infection and hepatitis. The results
indicate that HEV genotype 4 have the ability to cross species and
infect rabbits. As we have reported previously, genotype 1 and 4
HEV can infect monkeys and all animals were infected and
developed severe hepatitis [30]. It is noteworthy that the challenge
doses (the ratio of genome equivalents of virus to the weight of
animal) were similar in the rabbit and monkey models. Therefore,
the infectivity and pathogenicity of genotype 4 HEV in rabbits was
much lower than seen in non-human primate models of infection.
In summary, we infected rabbits successfully with rabbit HEV
and the clinical picture in these animals was similar to HEV
infection of monkeys. It seems that rabbits constitute a valuable
model to study the mechanisms of HEV replication and
pathogenesis. These studies indicate the rabbit model has potential
for the development of HEV vaccines and clinical therapies for the
treatment of infection.
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